Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Eligulashvili

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 26, 1998
Adverse neuropsychiatric events associated with dexfenfluramine and fenfluramineU D McCann, V Eligulashvili, G A Ricaurte
Neuropsychobiology|June 27, 2000
(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studiesU D McCann, V Eligulashvili, G A Ricaurte
Psychopharmacology|June 15, 1999
Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled studyU D McCann, M Mertl, V Eligulashvili, et al.
Psychopharmacology|December 11, 1999
Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) usersU D McCann, V Eligulashvili, M Mertl, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 26, 1998
Adverse neuropsychiatric events associated with dexfenfluramine and fenfluramineU D McCann, V Eligulashvili, G A Ricaurte
Neuropsychobiology|June 27, 2000
(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studiesU D McCann, V Eligulashvili, G A Ricaurte
Psychopharmacology|June 15, 1999
Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled studyU D McCann, M Mertl, V Eligulashvili, et al.
Psychopharmacology|December 11, 1999
Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) usersU D McCann, V Eligulashvili, M Mertl, et al.
Pageof 1